FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
After a winter of lockdowns and pandemic blues, summer is underway in the northern hemisphere and this brightens the outlook for City Chic
Amcor provided a robust update for the nine months to March yet detail is lacking on just how cost pressures will pan out
During April the ASX200 recorded a seventh consecutive monthly rise with the technology and resources sectors leading the way
FNArena’s series on bond investment continues with further information and explanation
Westpac has excited the market, outlining a significant cost target over three years. As always, the chorus is “show us the money”
Independent Investment Research updates developments in Australia’s listed investment trust and provides comparative data
Charter Hall has made a habit of upgrading guidance then beating this at the result. Now, FY21 has been upgraded for the third time
Over the short term ResMed could find it difficult to surmount obstacles created by the pandemic while there is general agreement on an eventual return to growth
Is the worst of the pandemic behind Coles now, signalled by several features of shopping behaviour that are starting to normalise?